Wegovy Leads Race to Release Weight-Loss Pill

Novo Nordisk announced its popular GLP-1 injectable Wegovy is now available in pill form with a prescription at more than 70,000 U.S. pharmacies including CVS, Costco and some telehealth providers. Drug makers have been fighting for the crown of an industry that analysts say could be worth $100 billion by the 2030s. NBC’s Emilie Ikeda reports and Dr. Roshini Raj joins TODAY to break down what you need to know about the new weight loss drug option.